10 Best Organ Transplant and Diagnosis Stocks To Buy Now

6. Zimmer Biomet Holdings, Inc. (NYSE:ZBH)

Market Cap as of August 1: $22.86 Billion

Hedge Funds Holding Stakes: 41

Zimmer Biomet Holdings, Inc. (NYSE:ZBH) is one of the top stocks with exposure in the organ and transplant sector. It designs, manufactures, and markets orthopedic reconstructive products like knee and hip products.

Zimmer Biomet Holdings, Inc. (NYSE:ZBH)’s focus on orthopedic and musculoskeletal products makes it one of the 10 best organ transplant and diagnosis stocks to buy now. Even though the stock is down by 9% for the year, it generated a 6.5% increase in sales in 2023 to $7.394 billion. Insider Monkey database indicates that the hedge funds holding stakes in Zimmer Biomet Holdings, Inc. (NYSE:ZBH) dropped to 41 in Q1 2024 from 49 as of the end of 2023.